KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Other Accumulated Expenses (2020 - 2025)

Historic Other Accumulated Expenses for LifeMD (LFMD) over the last 6 years, with Q3 2025 value amounting to $2.3 million.

  • LifeMD's Other Accumulated Expenses fell 3233.69% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year decrease of 3233.69%. This contributed to the annual value of $2.3 million for FY2024, which is 2780.11% up from last year.
  • According to the latest figures from Q3 2025, LifeMD's Other Accumulated Expenses is $2.3 million, which was down 3233.69% from $1.8 million recorded in Q2 2025.
  • Over the past 5 years, LifeMD's Other Accumulated Expenses peaked at $3.4 million during Q3 2024, and registered a low of $1.2 million during Q3 2021.
  • Moreover, its 5-year median value for Other Accumulated Expenses was $2.0 million (2023), whereas its average is $2.1 million.
  • As far as peak fluctuations go, LifeMD's Other Accumulated Expenses soared by 8895.77% in 2021, and later crashed by 3233.69% in 2025.
  • Over the past 5 years, LifeMD's Other Accumulated Expenses (Quarter) stood at $2.1 million in 2021, then fell by 9.24% to $1.9 million in 2022, then decreased by 3.94% to $1.8 million in 2023, then grew by 27.8% to $2.3 million in 2024, then dropped by 0.62% to $2.3 million in 2025.
  • Its Other Accumulated Expenses was $2.3 million in Q3 2025, compared to $1.8 million in Q2 2025 and $2.8 million in Q1 2025.